Texas has reached a settlement with AstraZeneca, resulting in the recovery of nearly $34 million. The pharmaceutical company was accused of using an illegal kickback scheme to influence Medicaid prescriptions.

The settlement resolves allegations that AstraZeneca improperly influenced prescription decisions. Further details about the case and settlement are available from the source.

The recovered amount of nearly $34 million is part of the settlement, but additional information about the case is not provided here. For more information, readers can refer to the original source.